Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments and Ethical-Legal Challenges
This series of articles investigates a broad range of legal, management, ethical, economic, and social issues associated with the translation and commercialization of regenerative medicine technologies and services. Articles published in this series were invited from delegates that attended Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments and Ethical-Legal Challenges, held In Toronto, ON, November 5-7, 2014. The organizers would like to thank the Stem Cell Network, the Cancer Stem Cell Consortium, Genome Canada, Genome Quebec, Genome Alberta, the Ontario Genomics Institute, the Canadian Institutes for Health Research, and Alberta Innovates-Health Solutions for their generous support of both this event.
All articles have been independently prepared by the authors and have been subject to the standard peer review processes of the journals.
- RESEARCH ARTICLE
Qualitative study on custodianship of human biological material and data stored in biobanks
Balancing the rights and obligations of custodians and applicants in relation to access to biobanks is of utmost importance to guarantee trust and confidence. This study aimed to reveal which issues divide dif...BMC Medical Ethics 2016 17:15Published on: 1 March 2016 - DEBATE
Unproven stem cell–based interventions and achieving a compromise policy among the multiple stakeholders
In 2004, patient advocate groups were major players in helping pass and implement significant public policy and funding initiatives in stem cells and regenerative medicine. In the following years, advocates we...BMC Medical Ethics 2015 16:75Published on: 4 November 2015 - DEBATE
The commercialization of university-based research: Balancing risks and benefits
The increasing push to commercialize university research has emerged as a significant science policy challenge. While the socio-economic benefits of increased and rapid research commercialization are often emp...BMC Medical Ethics 2015 16:70Published on: 14 October 2015 - RESEARCH ARTICLE
The gene patent controversy on Twitter: a case study of Twitter users’ responses to the CHEO lawsuit against Long QT gene patents
The recent Canadian lawsuit on patent infringement, filed by the Children’s Hospital of Eastern Ontario (CHEO), has engendered a significant public debate on whether patenting genes should be legal in Canada. ...BMC Medical Ethics 2015 16:55Published on: 25 August 2015 - RESEARCH ARTICLE
Challenges in the translation and commercialization of cell therapies
Cell therapies are an emerging form of healthcare that offer significant potential to improve the practice of medicine and provide benefits to patients who currently have limited or no treatment options. Ideal...BMC Biotechnology 2015 15:70Published on: 7 August 2015
.png)
No hay comentarios:
Publicar un comentario